Johnson & Johnson Innovation Center features collaboration with Tissue Regeneration Systems to develop bioresorbable, implantatable devices for skeletal reconstruction and bone regeneration Watch Video Here
Month: April 2015
α/β-Peptides Could Offer Low-Cost Alternative To Antibody Drugs
Samuel H. Gellman, William L. Murphy, Katrina T. Forest, and coworkers have designed a two-helix α/β-peptide with afffinity for VEGF and demonstrated its use by inhibiting the growth of cells lining blood vessels, a process …